1Takahashi T, Hagiwara A , Shimotuma M, et al. Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles. World Journal of Surgery, 1995, 19(4):565-569.
2Ohgaki M,Takenaka A,Shiomi A,et al.Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients[J].Gan To Kagaku Ryoho,2004,31(11):1858-1860.
3Ito T,Hagiwara A,Takagi T,et al.Local ainistration of methotrexate bound to activated carbon particles (MTX-CH) for treating cancers in mice[J].Anticancer Res,2003,23 (2B):1401-1404.
4Fujiyama J,Nakase Y,Mochizuki S,et al.Fundamental studies on locally injected methotrexate bound to activated carbon particles (MTX-CH)[J].Gan To Kagaku Ryoho,2004,31(11):1844-1846.
5Nakase Y,Hagiwara A,Kin S,et al.Intratumoral ainistration of methotrexate bound to activated carbon particles:antitumor effectiveness against human colon carcinoma xenografts and acute toxicity in mice[J].J Pharmacol Exp Ther,2004,311(1):382-387.
6Jansen M,Jansen PL,Fass J,et a1.Influence of intraperitoneal therapy with mitomycin C adsorbed on activated carbon on anastomotic and wound healing in rats[J].Dig Dis Sci,2002,47(9):1992-1997.
7Nishioka Y,Yoshino H.Lymphatic targeting with nanoparticulate system[J].Adv Drug Deliv Rev,2001,47(1):55-64.
8Shafik A,El Metnawy W,El Sibai O.Anal submucosal injection:a novel modality for the treatment of advanced rectal cancer[J].Eur J Surg Oncol,1999,25(1):76-81.
9Jianghao Chen,Ling Wang,Qing Yao,et al.Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer[J].Breast Cancer Research,2004,6(4):474-477.
10Hagiwara A.Toni T.Sewai K,et al.Local injection of anti-cancer-drugs bound to carbon particles for early gastric cancer-a pilot study[J].Hepatogastroenterology,2000,47(32):575-578.
